Danaher (NYSE:DHR) Misses Q1 CY2026 Revenue Estimates
WASHINGTON , April 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026. All results in this release reflect only continuing operations and...
Barchart Research What to Expect from DHR Earnings DHR Generated April 20, 2026 Current Price $195.50 EPS Estimate $$1.94 Consensus Rating Strong Buy Average Move 5.22% Danaher's Premium Multiple Meets...
Danaher (DHR) Q1 Earnings: What To Expect
Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Masimo Corporation...
Danaher Corporation is approaching its first-quarter earnings release in a few weeks, and Wall Street is forecasting a low single-digit percentage rise in earnings.